Delpark 2 mg (Tablet)

Unit Price: ৳ 5.50 (3 x 10: ৳ 165.00)
Strip Price: ৳ 55.00

Medicine Details

Indications

  • Adjunct in treatment of parkinsonism
  • Adjuvant therapy with levodopa
  • Control of extrapyramidal disorders
  • Treatment of postencephalitic, arteriosclerotic, and idiopathic parkinsonism

Description

  • Exerts direct inhibitory effect on parasympathetic nervous system
  • Relaxing effect on smooth musculature

Pharmacology

  • Non-selective muscarinic acetylcholine receptor antagonist
  • Higher affinity for M1 subtype
  • Higher affinity for central muscarinic receptors in cerebral cortex
  • Lower affinity for peripherally located receptors
  • Possible modification of nicotinic acetylcholine receptor neurotransmission
  • Enhanced dopamine release in the striatum

Dosage & Administration

  • Initial low dose, gradually increased
  • Individualized dosage
  • Preferable administration before or after meals based on patient's reaction
  • Potential need for small amounts of atropine in postencephalitic patients
  • Precautions for dry mouth
  • Abrupt withdrawal may result in exacerbation of symptoms or neuroleptic malignant syndrome
  • Different dosages for idiopathic parkinsonism, drug-induced parkinsonism, concomitant use with levodopa, and children
  • Best tolerated when divided into 3-4 doses at mealtimes

Interaction

  • Additive effects with cannabinoids, barbiturates, opiates, and alcohol
  • Increased sedative effects with alcohol or other CNS depressants
  • Intensification of anticholinergic effects with monoamine oxidase inhibitors and tricyclic antidepressants
  • Increased risk of tardive dyskinesia during concomitant administration of anticholinergics and neuroleptics
  • Possible need for reduction of levodopa dosage during concomitant therapy

Contraindications

  • Hypersensitivity to trihexyphenidyl
  • Narrow angle glaucoma

Side Effects

  • Dryness of the mouth
  • Blurred vision
  • Dizziness
  • Nausea
  • Nervousness
  • Suppurative parotitis
  • Skin rashes
  • Dilatation of the colon
  • Paralytic ileus
  • Psychiatric manifestations
  • Cognitive dysfunctions
  • Constipation
  • Drowsiness
  • Urinary hesitancy or retention
  • Tachycardia
  • Dilation of the pupil
  • Increased intraocular pressure
  • Choreiform movements
  • Weakness
  • Vomiting
  • Headache
  • Exacerbation of parkinsonism with abrupt treatment withdrawal
  • Neuroleptic malignant syndrome
  • Angle-closure glaucoma
  • Paradoxical sinus bradycardia
  • Dry skin
  • Cycloplegia
  • Hyperkinesia
  • Psychosis
  • Forgetfulness
  • Weight loss
  • Restlessness
  • Chorea
  • Sleep alterations

Pregnancy & Lactation

  • Use only if benefit outweighs risk during pregnancy
  • Caution in nursing women due to potential suppression of lactation

Precautions & Warnings

  • Gonioscope evaluation prior to therapy
  • Monitoring of intraocular pressures
  • Possibility of angle closure with increase in intraocular pressure
  • Administration caution in hot weather and concomitantly with other atropine-like drugs
  • Anhidrosis management in hot environments
  • Neuroleptic malignant syndrome risk with dose reduction or discontinuation
  • Hyperthermia consideration in presence of anhidrosis

Overdose Effects

  • Symptoms of atropine intoxication
  • Neuropsychiatric signs
  • Potential progression to stupor, coma, paralysis, cardiac and respiratory arrest, and death
  • Gastric lavage or methods to limit absorption
  • Administration of diazepam or barbiturate if CNS excitation observed
  • Contraindicated phenothiazines
  • Possible need for respiratory support, artificial respiration, or vasopressor agents

Therapeutic Class

  • Antiparkinson drugs

Storage Conditions

  • Store at temperature not exceeding 30°C
  • Dry place
  • Protection from light

Related Brands